AMED Insider Trading

Insider Ownership Percentage: 2.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Amedisys Insider Trading History Chart

This chart shows the insider buying and selling history at Amedisys by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Amedisys Share Price & Price History

Current Price: $92.70
Price Change: Price Decrease of -0.2 (-0.22%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for AMED up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$92.70Closing price on 03/29/25:

Amedisys Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Amedisys (NASDAQ:AMED)

94.36% of Amedisys stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AMED by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$839Mbought$221MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500M$0$500MTotal InflowsTotal Outflows
Amedisys logo
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Read More on Amedisys

Today's Range

Now: $92.70
Low: $92.65
High: $92.99

50 Day Range

MA: $92.28
Low: $90.43
High: $92.90

52 Week Range

Now: $92.70
Low: $82.15
High: $98.95

Volume

221,184 shs

Average Volume

396,120 shs

Market Capitalization

$3.04 billion

P/E Ratio

36.79

Dividend Yield

N/A

Beta

0.76

Who are the major institutional investors of Amedisys?

Amedisys' top institutional investors include:
  1. Vanguard Group Inc. — 9.82%
  2. FIL Ltd — 3.82%
  3. Pentwater Capital Management LP — 3.60%
  4. Caption Management LLC — 0.00%
  5. Norges Bank — 2.79%
  6. Alpine Associates Management Inc. — 2.71%
Learn More about top institutional investors of Amedisys stock.

Which major investors are selling Amedisys stock?

In the last quarter, AMED stock was sold by these institutional investors:
  1. Westchester Capital Management LLC
  2. Bank of America Corp DE
  3. Mackenzie Financial Corp
  4. Marshall Wace LLP
  5. SG Americas Securities LLC
  6. Natixis
  7. Renaissance Technologies LLC
  8. FIL Ltd

Which major investors are buying Amedisys stock?

Within the last quarter, AMED stock was acquired by institutional investors including:
  1. Caption Management LLC
  2. Norges Bank
  3. Wealthfront Advisers LLC
  4. Pentwater Capital Management LP
  5. Maven Securities LTD
  6. Balyasny Asset Management L.P.
  7. Pacer Advisors Inc.
  8. LMR Partners LLP